Top

Published in:

01-09-2009 | NEURO-EPIDEMIOLOGY

A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk

Authors: Cecilia Ahlgren, Kjell Torén, Anders Odén, Oluf Andersen

Published in: European Journal of Epidemiology | Issue 9/2009

Abstract

Viral infections are probably involved in the pathogenesis of multiple sclerosis (MS). A recent cohort study in the Gothenburg population revealed no change in MS incidence associated with the introduction of the Swedish measles, mumps and rubella vaccination programmes. The aim of the present study was to clarify whether these infections or vaccinations, and two other infections, varicella and infectious mononucleosis, influence MS risk. We performed a population-based case–control study in Gothenburg that included 509 MS cases and 2,067 controls, born 1959–1986. Data on infections and vaccinations were obtained from questionnaires and from child health and school health records. We found no significant associations between measles, mumps, rubella or varicella and MS risk. These results were consistent between the two source materials. Infectious mononucleosis was associated with significantly higher MS risk (odds ratio 2.03, 95% CI 1.52–2.73). Overall, there was no significant association between measles-mumps-rubella (MMR) vaccination and MS risk, while those MMR vaccinated before age ten only were at significantly higher MS risk (odds ratio 4.92, 95% CI 1.97–12.20). Those MMR vaccinated both before and after age ten had intermediate MS risk. Infection with measles, mumps, rubella and varicella did not influence MS risk in contrast to infectious mononucleosis which conferred doubled MS risk. The association with ‘early’ MMR vaccination only was an isolated finding, limited by a small number of subjects and multiple testing. Most likely this was a chance finding. Future studies could investigate it on an a priori basis.

Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J. 1971;3(5777):725–9.PubMedCrossRef

Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology. 1985;35(5):672–8.PubMed

Elian M, Nightingale S, Dean G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry. 1990;53(10):906–11.PubMedCrossRef

Sullivan CB, Visscher BR, Detels R. Multiple sclerosis and age at exposure to childhood diseases and animals: cases and their friends. Neurology. 1984;34(9):1144–8.PubMed

Compston DA, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain. 1986;109(Pt 2):325–44.PubMedCrossRef

Bachmann S, Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology. 1998;17(3):154–60.PubMedCrossRef

Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology. 2001;12(3):301–6.PubMedCrossRef

Vandvik B, Norrby E, Nordal HJ. Optic neuritis: local synthesis in the central nervous system of oligoclonal antibodies to measles, mumps, rubella, and herpes simplex viruses. Acta Neurol Scand. 1979;60(4):204–13.PubMedCrossRef

Salmi A, Reunanen M, Ilonen J, Panelius M. Intrathecal antibody synthesis to virus antigens in multiple sclerosis. Clin Exp Immunol. 1983;52(2):241–9.PubMed

10.

Bray PF, Luka J, Culp KW, Schlight JP. Antibodies against Epstein–Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology. 1992;42(9):1798–804.PubMed

11.

Frederiksen JL, Sindic CJ. Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI. Mult Scler. 1998;4(1):22–6.PubMedCrossRef

12.

Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler. 1998;4(3):111–7.PubMed

13.

Rand KH, Houck H, Denslow ND, Heilman KM. Epstein–Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci. 2000;173(1):32–9.PubMedCrossRef

14.

Bednarova J, Stourac P, Adam P. Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol Scand. 2005;112(2):97–102.PubMedCrossRef

15.

Petereit HF, Reske D. Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients-follow-up and clinical implications. Cerebrospinal Fluid Res. 2005;2:3.PubMedCrossRef

16.

Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res. 2006;28(3):236–44.PubMedCrossRef

17.

Poskanzer DC, Sever JL, Sheridan JL, Prenney LB. Multiple sclerosis in the Orkney and Shetland Islands. IV: viral antibody titres and viral infections. J Epidemiol Community Health. 1980;34(4):258–64.PubMedCrossRef

18.

Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein–Barr virus in multiple sclerosis: a prospective study. Neurology. 2004;62(12):2277–82.PubMed

19.

Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851–62.PubMedCrossRef

20.

Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 1993;72(4):551–60.PubMedCrossRef

21.

Bjorvatn B, Skoldenberg B. [Meningitis in mumps and orchitis in Stockholm during 1955–1976—an epidemiological background for a vaccination policy] In Swedish. Lakartidningen. 1978;75(23):2295–8.PubMed

22.

Christenson B, Bottiger M. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule. Vaccine. 1991;9(5):326–9.PubMedCrossRef

23.

Taranger J. Vaccination programme for eradication of measles, mumps, and rubella. Lancet. 1982;1(8277):915–6.PubMedCrossRef

24.

Strom J. Social development and declining incidence of some common epidemic diseases in children. A study of the incidence in different age groups in Stockholm. Acta Paediatr Scand. 1967;56(2):159–63.PubMedCrossRef

25.

Strom J. [On the incidence of common epidemics of infectious diseases in the light of conditions in Stockholm.] In Swedish. Soc Med Tidskr. 1959;36:347–54.PubMed

26.

Lundstrom R, Svedmyr A, Hagbard L, Kaijser K. Rubella immunity as related to age and history of overt disease. Acta Paediatr Scand. 1967;56(3):279–85.PubMedCrossRef

27.

Ahlgren C, Oden A, Toren K, Andersen O. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand. 2009;119(5):313–20.PubMedCrossRef

28.

Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227–31.PubMedCrossRef

29.

Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346(3):158–64.PubMedCrossRef

30.

McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–7.PubMedCrossRef

31.

Italian Multiple Sclerosis Study Group. Migration and infectious diseases in etiology of multiple sclerosis: a case–control study. In: Battaglia M, editor. Multiple sclerosis research : proceedings of the international multiple sclerosis conference: an update on multiple sclerosis (1989) 15–17 Sep 1988. Rome Excerpta Medica; 1989. p. 147–58.

32.

Gronning M, Riise T, Kvale G, Albrektsen G, Midgard R, Nyland H. Infections in childhood and adolescence in multiple sclerosis. A case–control study. Neuroepidemiology. 1993;12(2):61–9.PubMedCrossRef

33.

Bager P, Nielsen NM, Bihrmann K, Frisch M, Hjalgrim H, Wohlfart J, et al. Childhood infections and risk of multiple sclerosis. Brain. 2004;127(Pt 11):2491–7.PubMedCrossRef

34.

Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort JM. Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler. 2008;14(3):307–13.PubMedCrossRef

35.

Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006;59(3):499–503.PubMedCrossRef

36.

Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Haahr S, Sorensen PS, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007;64(1):72–5.PubMedCrossRef

37.

Huseby ES, Sather B, Huseby PG, Goverman J. Age-dependent T cell tolerance and autoimmunity to myelin basic protein. Immunity. 2001;14(4):471–81.PubMedCrossRef

38.

DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol. 2003;60(4):504–9.PubMedCrossRef

Title: A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk
Authors: Cecilia Ahlgren
Kjell Torén
Anders Odén
Oluf Andersen
Publication date: 01-09-2009
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 9/2009
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-009-9367-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2009

The Mothers and Children’s Environmental Health (MOCEH) study

Work as a physician and adverse pregnancy outcomes: a Finnish nationwide population-based registry study

Sonographic assessment of abdominal fat distribution in infancy

Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978–2003

Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study

The association between birthplace in different regions of the world and cardiovascular mortality among residents of Spain